SEC Comment Letter for GENETIC TECHNOLOGIES LTD (GENE, GNTLF) (CIK 0001166272) — Mar 19, 2020
GENETIC TECHNOLOGIES LTD (GENE, GNTLF) (CIK 0001166272)
Date: March 19, 2020 · CIK: 0001166272 · Accession: 0000000000-20-002459
AI Filing Summary & Sentiment
File numbers found in text: 333-237152
Letter
March 19, 2020 Jerzy Muchnicki Interim Chief Executive Officer Genetic Technologies Limited 60-66 Hanover Street Fitzroy, Victoria, 3065, Australia Re:Genetic Technologies Limited Registration Statement on Form F-3 Filed March 13, 2020 File No. 333-237152 Dear Dr. Muchnicki: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at (202) 551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Darrin M. Ocasio, Esq.
Show Raw Text
March 19, 2020
Jerzy Muchnicki
Interim Chief Executive Officer
Genetic Technologies Limited
60-66 Hanover Street
Fitzroy, Victoria, 3065, Australia
Re:Genetic Technologies Limited
Registration Statement on Form F-3
Filed March 13, 2020
File No. 333-237152
Dear Dr. Muchnicki:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at (202) 551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Darrin M. Ocasio, Esq.